An interventional study of Selective Intraperineural Nerve Root Block(SINRB) and single-level lumbar decompression surgery in Radiculopathy Lumbar, Radiculopathy Sacral and Radiculopathy Multiple Sites, sponsored by Xi'an Honghui Hospital. Not yet recruiting at 1 site in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-04-15.
Sponsored by Xi'an Honghui Hospital · Not applicable, Interventional, and Diagnostic
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 52 studies in Intervertebral Disc Displacement with a site in China — 13 open to participants now, 14 under way, none of them phase 3. Intervertebral Disc Displacement · China.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, this one is the 25th largest by planned enrollment of the 41 interventional ones that give a count, is one of 4 that started in 2026, is one of 35 with no phase, reaches primary completion later than 5 of the 13 other live ones, and was the 44th registered.
474 studies on the registry are indexed under Intervertebral Disc Displacement; 98 are open to participants now.
Browse Intervertebral Disc Displacement studies →13 of the 52 studies in Intervertebral Disc Displacement with a site in China are open now. Recruiting first, the newest first:
Fan Zhang · Sites in China
Ages 18–75
The Affiliated Hospital of Qingdao University · Sites in China
Ages 12–65
Li Xiang · Sites in China
Ages 19–65
Peking University Third Hospital · Sites in China
Ages 18–80
The Third Affiliated hospital of Zhejiang Chinese Medical University · Sites in China
Ages 20–60 · Healthy volunteers
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 48 Intervertebral Disc Displacement studies recruiting now, 20 (42%) set no upper age limit and 24 (50%) stop at 75 or younger; 3 take children under 18; 6 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
52 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is above the median of 63 across 344 interventional studies indexed under Intervertebral Disc Displacement.
Median enrollment 90 across the 41 interventional studies, 120 across the 11 observational. Of the 19 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 52 has an industry lead sponsor. The 10 most frequent:
Xi'an Honghui Hospital is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Xi'an Honghui Hospital has 1 study filed under Intervertebral Disc Displacement — fewer than ten, so there is no comparison to draw.
5 of the studies in Intervertebral Disc Displacement with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07161232Li XiangThe Influence of the Timing of Postoperative Rehabilitation Intervention on the Clinical Efficacy of Unilateral Biportal Endoscopic Spine System in the Treatment of Lumbar Disc Herniation | 2026-11-28 |
| NCT07531485Xi'an Honghui HospitalThe Selective Intraperineural Nerve Root Block Study | 2026-12-01 |
| NCT07250581The Affiliated Hospital of Qingdao UniversityA Randomized Trial of Annular Repair With Discectomy Versus Discectomy Alone for Lumbar Disc Herniation | 2026-12-31 |
| NCT07728149The Third Affiliated hospital of Zhejiang Chinese Medical UniversityBrain Connectomic Mechanisms of Spinal Manipulative Therapy on LDH Analgesia Based on Multimodal MRI | 2027-09 |
| NCT06591442Wuhan Union Hospital, ChinaScreening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient | 2027-09-03 |
Add all 5 to your calendar (.ics) → With an account.
Among the 52 studies in Intervertebral Disc Displacement with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Before lumbosacral decompression surgery for radicular pain, selective nerve root block(SNRB) is a common procedure to identify the responsible compressed nerve root(RCNR) and predict surgical outcomes. However, the diagnostic accuracy of conventional SNRB is unsatisfactory, especially in terms of specificity. The main limitation is the uncontrolled distribution of anesthetics during injection: when anesthetics spread to surrounding soft tissues instead of acting directly on the RCNR, false-negative results may occur with persistent radicular pain; when anesthetics diffuse to two or more nerve roots including the RCNR, false-positive results may occur even if a normal nerve root is punctured, leading to misdiagnosis.
This study aims to evaluate the diagnostic accuracy of a novel three-dimensional computed tomography multiplanar volume reconstruction (3D-CT MPVR) guided selective intraperineural nerve root block(SINRB) for identifying the RCNR in patients with lumbosacral radicular pain. The investigators hypothesize that this technique will achieve higher diagnostic specificity and overall accuracy than conventional SNRB, by ensuring anesthetics are delivered directly to the target nerve root. This improvement will help clinicians make more accurate surgical plans, achieve better targeted decompression, and ultimately improve postoperative pain relief and functional recovery for patients.
The main research questions to be addressed in this study are:
Participants will:
[Background] It has been reported that approximately 85% of sciatica cases result from nerve root compression secondary to lumbar disc herniation or lumbar spinal stenosis, a clinical entity defined as radicular pain that manifests as radiating pain involving the buttocks and lower extremities. For patients with an inadequate response to conservative management, surgical decompression of the compressed nerve root serves as a conventional and highly effective therapeutic option. Furthermore, if the pain generator can be confirmed to arise from a single nerve root, targeted single-level decompression of that individual nerve root is generally sufficient for pain relief. However, limitations of conventional imaging examinations coupled with overlapping innervation territories of multiple lumbosacral nerve roots often make accurate identification of the symptomatic compressed nerve root challenging in certain patient populations. Misidentification of the pathological nerve root may consequently lead to surgical failure. To address this clinical dilemma, diagnostic selective nerve root block (SNRB) is regarded as the most valuable adjunct modality. In routine clinical practice, complete pain remission following SNRB indicates that the nerve root infiltrated by local anesthetics is the primary pain source.
Regrettably, prior relevant studies have demonstrated that conventional SNRB exhibits relatively low overall diagnostic accuracy, failing to achieve satisfactory sensitivity and specificity simultaneously. Uncontrolled diffusion of injectable agents is recognized as the predominant contributor to such poor diagnostic performance. Specifically, unintended anesthetic contamination of adjacent unaffected nerve roots may trigger false-positive outcomes, while insufficient delivery of local anesthetics to the targeted nerve root can result in false-negative findings. At present, no techniques or strategies for precisely regulating drug distribution during SNRB procedures have been reported in the existing literature.
Interestingly, during the nerve root fluorography in some patients in our team, when linear striation opacities are visualized within the nerve root, which indicates occurrence of intraperineural, the contrast medium typically diffuses only inside and around the targeted nerve root. This phenomenon can also be observed in the illustrative images from a previous study on therapeutic SNRB, yet it seems to have attracted little attention from researchers. Additionally, the findings of this study demonstrated that intraperineural injection occurred in approximately 30% of patients undergoing therapeutic SNRB with accidental intraperineural injection, and no cases of neurological injury were documented during follow-up. Therefore, it is reasonable to hypothesize that intraperineural injection is a safe, feasible approach that enables precise distribution of agents to the targeted nerve root.
Using the postoperative efficacy of single-segment single-nerve-root decompression as the gold standard for identifying the compressed nerve root, the present study aimed to investigate the diagnostic accuracy, safety, and technical feasibility of selective intraperineural nerve root block (SINRB) in patients with radicular pain. A double-blind approach was implemented, with participants and assessors masked to the nerve root status (responsible vs. non-responsible) during evaluations. Meanwhile, to improve the success rate of intraperineural injection, to the best of our knowledge, the present study is the first to adopt three-dimensional computed tomography multiplanar volume reconstruction (3D-CT MPVR) imaging to visualize the anatomical course of the nerve root within the intervertebral foramen.
[Sample Size Estimation] To ensure adequate statistical power for accurately evaluating the diagnostic accuracy of selective intraperineural nerve root block (SINRB) in identifying the responsible compressed nerve root (RCNR) in patients with radicular pain, sample size calculation was performed based on diagnostic test design principles, incorporating the following key parameters: (from preliminary pilot data) an expected sensitivity of 95%, specificity of 96%, 95% confidence level, ±5% margin of error, and a 10% allowance for potential missing data or patient dropout. Using the single-proportion estimation method, the required numbers of positive and negative events were calculated separately for sensitivity and specificity. The sample size required for sensitivity was 80 cases, and for specificity was 66 cases. Accordingly, we plan to enroll 66 patients with single-level lesions (anticipated to yield one positive and one negative result each) and 14 patients with multi-level lesions (anticipated to yield one positive result each). This sample size sufficiently meets the statistical power requirements for the primary study objective-evaluating the sensitivity and specificity of SINRB for RCNR identification-ensuring the scientific rigor, stability, and generalizability of the study findings.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Cancer (malignancy)
Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.
Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All enrolled subjects will undergo the same standardized surgical procedure. * For patients with a single suspected lesion and RCNR (typically with ambiguous imaging findings), 2 separate SINRBs are performed (firstly at a non-responsible control root, then at the suspected RCNR) to rule out placebo effect and non-lumbar pain sources. If ≥50% pain relief occurs after the first block, the second SINRB is given the next day after local anesthetic clearance, and patients compare pain relief differences between the two sessions. If relief is less than 50%, the second SINRB is delivered after a 20-minute interval. * For patients with multiple nerve roots compressed, 1 SINRB is performed at the target nerve root to confirm that single-level surgical decompression can achieve complete pain relief. If complete pain relief or resolution of motor dysfunction is not achieved after the first injection, a second SINRB will be administered to an alternative suspected root to identify the true RCNR.
Diagnostic Test: Selective Intraperineural Nerve Root Block(SINRB) · Procedure: single-level lumbar decompression surgery
The patient was placed in a standard prone position. The cutaneous puncture point was confirmed via large C-arm oblique fluoroscopy with the projection angle strictly consistent with the preoperative protocol.All puncture manipulations were completed by an experienced spinal surgeon. Under intermittent fluoroscopic guidance, the puncture trajectory was adjusted to keep the needle parallel to the fluoroscopic beam, followed by slow needle advancement until radiating pain was evoked in the patient. The needle was further advanced approximately 1 mm, and 0.2 mL contrast medium was injected subsequently. The visualization of a linear streak shadow within the nerve root confirmed intraneural positioning. The needle was fixed in situ, and 0.5 mL lidocaine was injected.
All patients underwent single-level lumbar surgery with either endoscopic or conventional open single nerve root decompression, and postoperative anteroposterior and lateral lumbar radiographs were routinely obtained for imaging evaluation.
The change from baseline in standing impairment
Standing impairment was documented via separate video recordings before and after each SINRB procedure, as well as on the second day of postoperative ambulation. Upon completion of data collection, Video recordings of all participants were randomly shuffled, and independent assessors evaluated the presence or absence of standing impairment for each video. Assessors were blinded to the type of nerve root injected (responsible vs. non-responsible), final surgical outcomes, clinical information, imaging results, and the number of SINRB sessions. Video content: The patient was instructed to stand upright with chest out, head raised, and lumbar spine maintained in an extended position for 20 seconds. Assessment Criteria: Standing impairment was defined as present if the patient voluntarily bent forward/backward or left/right during the test due to intolerable radicular pain and failed to maintain the initial upright posture. Otherwise, standing impairment was considered absent.
Time frame: Baseline, 5mins after SINRB, the second day after ambulation, and 1 month postoperatively
Change from baseline in walking impairment
Walking impairment was evaluated using the same recording and blinding protocols as those for standing impairment. Video content: Patients maintained an upright position and kept uninterrupted walking for 500 meters. Judgment criteria: "walking disorder" was defined as present if voluntary termination of walking occurred before completing 500 meters due to intolerable radicular pain. Otherwise, walking impairment was considered absent.
Time frame: Baseline, 5mins after SINRB, the second day after ambulation, and 1 month postoperatively
Change from baseline in straight leg raising impairment
The straight leg raising (SLR) impairment was evaluated using the same recording and blinding protocols as those for standing impairment. Video content: The straight leg raising (SLR) test was performed sequentially on the unaffected side and the affected side. Assessment criteria: The projection of the heel of the elevated leg onto the contralateral (non-elevated) leg was used as the observation index. "Presence of SLR impairment on the affected side" was defined as: the heel projection on the affected side failing to reach the patella due to intolerable radicular pain, whereas the heel projection on the unaffected side reached the patella or cephalad to it. "Absence of SLR impairment on the affected side" was defined as: the heel projection reaching the patella at maximum SLR on the affected side, with or without tolerable radicular pain.
Time frame: Baseline, 5mins after SINRB, the second day after ambulation, and 1 month postoperatively
Subjective pain relief
After each SINRB/operation, movements previously inducing severe pain (e.g., standing, walking, lying flat, stair climbing/descending) were repeated. Video questions: "Where was your worst pain during movement pre-procedure?"; "Where do you feel pain now? Point to it."; "Does residual pain affect walking speed/distance?"; "How much has pain decreased post-SINRB/surgery?" (options: no significant relief; relief with activity-limiting residual pain; essential relief \[residual pain not affecting activities\]; pain disappeared). Pain relief assessment followed the same recording and blinding protocols as for standing impairment.
Time frame: 5mins after SINRB, the second day after ambulation, and 1 month postoperatively
Result of SINRB
This outcome measure is a derived variable automatically generated from the primary outcome measure according to a predefined scoring rule. After the independent assessors completed evaluating activity impairment and subjective pain relief in each video, all results were matched with corresponding patients and tabulated. SINRB test results were judged by the following criteria: For patients with activity impairment, results were positive if all activity impairments resolved (with or without residual pain), otherwise negative. For patients without activity impairment, results were positive if subjective pain relief was rated as "pain disappeared", otherwise negative.
Time frame: 5mins after SINRB
Overall clinical assessment after lumbar spine surgery
This outcome measure is a derived variable automatically generated from the primary outcome measure according to a predefined scoring rule. Compared with preoperative status, if all movement impairments resolve postoperatively, or the original pain is rated as "essential relief" or "pain disappeared", the decompressed nerve root is defined as the true responsible compressed nerve root(RCNR) and the sole source of pain. If pain relief does not meet the above criteria during the initial postoperative assessment, a telephone follow-up will be conducted at 1 month after surgery for re-evaluation. If the patient reports "essential relief" or "pain disappeared" at follow-up, the decompressed nerve root is still regarded as the RCNR and the sole source of pain; otherwise, it is not considered the sole source of pain.
Time frame: the second day after ambulation, and 1 month postoperatively
The occurrence of complications
The occurrence of complications during the puncture procedure, including hematoma at the puncture site, infection, allergic reactions, and other related complications, will be recorded in detail.
Time frame: 24hs after SINRB
Changes in neurological function before and after SINRB
Changes in neurological function before and after SINRB. Baseline neurological assessment is performed before the first SINRB, including superficial sensory examination of the affected side (medial malleolus , dorsum of the foot, first and second toe web spaces , lateral aspect of the heel) and muscle strength testing of the affected side (ankle dorsiflexion, ankle plantarflexion, great toe dorsiflexion, great toe plantarflexion). At 24 hours after complete resolution of anesthetic effects following the final SINRB, patients are interviewed for new-onset numbness or discomfort, and the above neurological examinations are repeated. To supervise this key data, video recording will be conducted during inquiry and physical examination, with subsequent quality supervision by third-party senior physicians.
Time frame: 24hs after SINRB
Success rate of SINRB procedure
The SINRB procedure is clinically successful when intraperineural injection is achieved without contrast/drug contamination per fluoroscopic criteria: 1. Drug contamination: Post-lidocaine final radiculography showing contrast extending beyond the target nerve root and spreading along the dura to adjacent nerve roots; otherwise negative. 2. Definition of successful intraperineural injection The injection is judged as successful when all three fluoroscopic imaging features are satisfied simultaneously: * Tubular outline of the nerve root and the linear striated opacification within the nerve root is noted after the contrast material injection; * After lidocaine delivery, the striated opacification around the needle tip is diluted or disappeared; * Re-enhancement of the striated nerve root opacification is observed after supplementary contrast medium reinjection.
Time frame: immediately post-SINRB
Plan to share: No — Due to ethical restrictions and patient privacy confidentiality requirements, individual participant data will not be shared
Start is estimated for Apr 2026; primary completion for Dec 2026, 7 months later.
Of 178 non-industry interventional studies with no phase under Intervertebral Disc Displacement, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 23. This study's planned 7 months is below that.
Counting every sponsor, half of 191 studies reached it within 12 months; a quarter within 5 and three quarters within 27.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Intervertebral Disc Displacement →